GlassScriptPhysician profile
Travis Joe Small
NPI 1881905511
$39,377.59
in general payments reported to CMS, 2019-2025
21 companies · $2,760 in 2025
The $2,760 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,297 · 2020: $2,647 · 2021: $3,426 · 2022: $1,680 · 2023: $8,764 · 2024: $14K · 2025: $2,760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $6,952 · Travel and Lodging: $3,251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,125.00 |
| Food and Beverage | $6,951.75 |
| Travel and Lodging | $3,250.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $22,017.11 | 2020-2025 | Icona Stem (Fka Abc Stem), Omnibotics 3.0, Corin Hips |
| Stryker Corporation | $10,236.67 | 2019-2025 | Mako, Insignia, Asnis |
| Medacta USA, INC. | $3,073.99 | 2019-2025 | Amistem, Gmk Sphere, Gmk Revision |
| Smith+Nephew, INC. | $2,239.84 | 2019-2025 | Journey, Or3o Dual Mobility, Ri Hip Navigation |
| Naviswiss, INC. | $586.30 | 2023-2024 | Naviswiss Hip/Knee Navigation |
| Medtronic, INC. | $327.71 | 2022-2025 | Aquamantys(Tm) |
| Linkbio Corp | $271.38 | 2024 | |
| Alafair Biosciences, INC. | $153.64 | 2024 | Versawrap |
| Acell, INC. | $92.51 | 2019 | |
| Bioventus LLC | $85.50 | 2023-2025 | Durolane, Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Zimmer Biomet Holdings, INC. | $46.14 | 2025 | Persona |
| Amgen INC. | $37.62 | 2022 | |
| Osteocentric Technologies, INC. | $32.97 | 2020 | |
| Baxter Healthcare | $30.56 | 2025 | Tisseel |
| Davol INC. | $27.60 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $26.47 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.01 | 2025 | Iovera, Zilretta |
| Pylant Medical | $19.76 | 2019 | |
| Orthalign INC | $18.34 | 2025 | Orthalign Plus |
| Supernus Pharmaceuticals, INC. | $18.27 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Small listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.